Search Results - "Stefansson, M."

Refine Results
  1. 1
  2. 2

    Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features by Ingebriktsen, L M, Humlevik, R O C, Svanøe, A A, Sæle, A K M, Winge, I, Toska, K, Kalvenes, M B, Davidsen, B, Heie, A, Knutsvik, G, Askeland, C, Stefansson, I M, Hoivik, E A, Akslen, L A, Wik, E

    Published in Breast cancer research : BCR (28-08-2024)
    “…Aurora kinase A (AURKA) is reported to be overexpressed in breast cancer. In addition to its role in regulating cell cycle and mitosis, studies have reported…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer by Krüger, Kristi, Silwal-Pandit, Laxmi, Wik, Elisabeth, Straume, Oddbjørn, Stefansson, Ingunn M., Borgen, Elin, Garred, Øystein, Naume, Bjørn, Engebraaten, Olav, Akslen, Lars A.

    Published in Scientific reports (09-02-2021)
    “…A subset of breast cancer patients benefits from preoperative bevacizumab and chemotherapy, but validated predictive biomarkers are lacking. Here, we aimed to…”
    Get full text
    Journal Article
  5. 5

    Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays by Knutsvik, Gøril, Stefansson, Ingunn M, Aziz, Sura, Arnes, Jarle, Eide, Johan, Collett, Karin, Akslen, Lars A

    Published in PloS one (06-11-2014)
    “…Tumor cell proliferation in breast cancer is strongly prognostic and may also predict response to chemotherapy. However, there is no consensus on counting…”
    Get full text
    Journal Article
  6. 6

    Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer by COLLETT, Karin, EIDE, Geir E, ARNES, Jarle, STEFANSSON, Ingunn M, EIDE, Johan, BRAATEN, Audun, AAS, Turid, OTTE, Ariel P, AKSLEN, Lars A

    Published in Clinical cancer research (15-02-2006)
    “…The polycomb group protein enhancer of zeste homologue 2 (EZH2) has been linked to invasive properties of aggressive breast cancer. In this report, tissue…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer by Foulkes, William D., Stefansson, Ingunn M., Chappuis, Pierre O., Bégin, Louis R., Goffin, John R., Wong, Nora, Trudel, Michel, Akslen, Lars A.

    “…A basal epithelial phenotype is found in not more than 15% of all invasive breast cancers. Microarray studies have shown that this phenotype is associated with…”
    Get full text
    Journal Article
  9. 9

    Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer by TROVIK, Jone, WIK, Elisabeth, SALVESEN, Helga B, STEFANSSON, Ingunn M, MARCICKIEWICZ, Janusz, TINGULSTAD, Solveig, STAFF, Anne C, NJOLSTAD, Tormund S, VANDENPUT, Ingrid, AMANT, Frederic, AKSLEN, Lars A

    Published in Clinical cancer research (15-05-2011)
    “…Overexpression of the oncogen Stathmin has been linked to aggressive endometrial carcinoma and a potential for PI3Kinase inhibitors in this disease. We wanted…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Vascular proliferation is important for clinical progress of endometrial cancer by STEFANSSON, Ingunn M, SALVESEN, Helga B, AKSLEN, Lars A

    Published in Cancer research (Chicago, Ill.) (15-03-2006)
    “…Angiogenesis is essential for tumor growth, invasion, and metastatic spread. Whereas microvessel density (MVD) has been widely used as a measure of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Prognostic Impact of Alterations in P-Cadherin Expression and Related Cell Adhesion Markers in Endometrial Cancer by STEFANSSON, Ingunn M, SALVESEN, Helga B, AKSLEN, Lars A

    Published in Journal of clinical oncology (01-04-2004)
    “…Reduced tumor cell adhesion is associated with invasive growth and unfavorable prognosis. In endometrial carcinoma, the prognostic impact of adhesion markers…”
    Get full text
    Journal Article
  16. 16
  17. 17

    An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer by Mannelqvist, Monica, Wik, Elisabeth, Stefansson, Ingunn M, Akslen, Lars A

    Published in PloS one (06-06-2014)
    “…Vascular invasion by tumor cells is known to be important for cancer progression. By microarray and qPCR analyses, we earlier identified an 18-gene signature…”
    Get full text
    Journal Article
  18. 18

    A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors by COLLETT, Karin, STEFANSSON, Ingunn M, EIDE, Johan, BRAATEN, Audun, HEGE WANG, EIDE, Geir Egil, THORESEN, Steinar Ø, FOULKES, William D, AKSLEN, Lars A

    “…Interval breast cancer reduce the effectiveness of mammography screening programs. We studied 95 interval cancers, diagnosed during 1996 to 2001 as part of the…”
    Get full text
    Journal Article
  19. 19

    Pleistocene genetic legacy suggests incipient species of Sebastes mentella in the Irminger Sea by Stefánsson, M O, Sigurdsson, T, Pampoulie, C, Daníelsdóttir, A K, Thorgilsson, B, Ragnarsdóttir, A, Gíslason, D, Coughlan, J, Cross, T F, Bernatchez, L

    Published in Heredity (01-05-2009)
    “…To investigate a possible speciation event within the redfish (Sebastes mentella) complex in the Irminger Sea, we examined genetics, traditional morphology,…”
    Get full text
    Journal Article
  20. 20

    The genetic spectrum of a population-based sample of familial hemiplegic migraine by Thomsen, L. L., Kirchmann, M., Bjornsson, A., Stefansson, H., Jensen, R. M., Fasquel, A. C., Petursson, H., Stefansson, M., Frigge, M. L., Kong, A., Gulcher, J., Stefansson, K., Olesen, J.

    Published in Brain (London, England : 1878) (01-02-2007)
    “…Familial hemiplegic migraine (FHM) is a rare subtype of migraine with aura and transient hemiplegia. FHM mutations are known in three genes, the CACNA1A (FHM1)…”
    Get full text
    Journal Article